Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Molecular Mechanisms Underlying the Effects of Statins in the Central Nervous System.
Correction: Adherence to Interferon β-1b Treatment in Patients with Multiple Sclerosis in Spain.
Assessing walking disability in multiple sclerosis.
Subcortical atrophy and cognition: Sex effects in multiple sclerosis.
Tremor reduction and quality of life after deep brain stimulation for multiple sclerosis-associated tremor.
1,25-Dihydroxyvitamin D3 selectively and reversibly impairs T helper-cell CNS localization.
The path to self-management: a qualitative study involving older people with multiple sclerosis.
Severe septal panniculitis in a multiple sclerosis patient treated with interferon-beta.
Enhanced sphingosine-1-phosphate receptor 2 expression underlies female CNS autoimmunity susceptibility.
Accentia Biopharmaceuticals Announces that Revimmune Autoimmune Disease Therapy is Featured in Peer-review Journal
Extensive loss of connexins in Baló's disease: evidence for an auto-antibody-independent astrocytopathy via impaired astrocyte-oligodendrocyte/myelin interaction.
Extracranial Venous Drainage Patterns in Patients with Multiple Sclerosis and Healthy Controls.
Inhibition of Interferon-beta Responses in Multiple Sclerosis Immune Cells Associated With High-Dose Statins.
Vitamin D Responsive Elements within the HLA-DRB1 Promoter Region in Sardinian Multiple Sclerosis Associated Alleles.
Preclinical retinal neurodegeneration in a model of multiple sclerosis.
No Association Between Conventional Brain MR Imaging and Chronic Cerebrospinal Venous Insufficiency in Multiple Sclerosis.
The risk of Bipolar Disorders in Multiple Sclerosis.
Assessing the role of patient support services on adherence rates in patients using glatiramer acetate for relapsing-remitting multiple sclerosis.
Safety and Tolerability of Glatiramer Acetate (GLACIER)
Riluzole increases high-affinity glutamate uptake in rat spinal cord synaptosomes.
Riluzole, a novel antiglutamate, prevents memory loss and hippocampal neuronal damage in ischemic gerbils.
The role of myelin oligodendrocyte glycoprotein in autoimmune demyelination: a target for multiple sclerosis therapy?
Distribution of Brain Sodium Accumulation Correlates with Disability in Multiple Sclerosis: A Cross-sectional 23Na MR Imaging Study.
Myotonic dystrophy type 2 and multiple sclerosis: Case report.
Revisiting brain atrophy and its relationship to disability in multiple sclerosis.
Pages
« first
‹ previous
…
179
180
181
182
183
184
185
186
187
…
next ›
last »